|
Titan Pharmaceuticals Inc (NASDAQ: TTNP) |
|
Titan Pharmaceuticals Inc
TTNP's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Titan Pharmaceuticals Inc 's sales fell
in IV. Quarter 2024 from the same quarter a year ago.
Biotechnology & Pharmaceuticals industry recorded
deterioration of revenues by -2.61 %
Titan Pharmaceuticals Inc net loss decreased from $-2 millions, to $-1 millions in IV. Quarter 2024,
• More on TTNP's Growth
|
|
Titan Pharmaceuticals Inc realized a net loss in trailing twelve months.
Titan Pharmaceuticals Inc realized cash reduction of $ -4.38 per share in trailing twelve-month period. Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.55.
• More on TTNP's Valuation
|
|
|
|
|
Titan Pharmaceuticals Inc realized net loss in trailing twelve months.
Titan Pharmaceuticals Inc realized cash outflow of $ -4.38per share in trailing twelve-month period. Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.55.
Titan Pharmaceuticals Inc Price to Book Ratio is at 1.55 lower than Industry Avg. of 1411.8. and higher than S&P 500 Avg. of 0.01
• More on TTNP's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com